131 related articles for article (PubMed ID: 31004874)
21. Chemicals of environmental concern as inhibitors of human placental 3β-hydroxysteroid dehydrogenase 1 and aromatase: Screening and docking analysis.
Tang L; Shi L; Tang Y; Ying Y; Dong Y; Li H; Ge RS
Chem Biol Interact; 2022 Dec; 368():110243. PubMed ID: 36374910
[TBL] [Abstract][Full Text] [Related]
22. HSD3B1 variant and androgen-deprivation therapy outcome in prostate cancer.
Han FF; Ren LL; Xuan LL; Lv YL; Liu H; Gong LL; An ZL; Liu LH
Cancer Chemother Pharmacol; 2021 Jan; 87(1):103-112. PubMed ID: 33141329
[TBL] [Abstract][Full Text] [Related]
23. 3 beta-hydroxysteroid dehydrogenase isomerase (3beta-HSD) activity in the rat sciatic nerve: kinetic analysis and regulation by steroids.
Coirini H; Gouézou M; Delespierre B; Schumacher M; Guennoun R
J Steroid Biochem Mol Biol; 2003 May; 85(1):89-94. PubMed ID: 12798361
[TBL] [Abstract][Full Text] [Related]
24. HSD3B1 status as a biomarker of androgen deprivation resistance and implications for prostate cancer.
Hettel D; Sharifi N
Nat Rev Urol; 2018 Mar; 15(3):191-196. PubMed ID: 29231195
[TBL] [Abstract][Full Text] [Related]
25. Role of Cryptochrome-1 and Cryptochrome-2 in Aldosterone-Producing Adenomas and Adrenocortical Cells.
Tetti M; Castellano I; Venziano F; Magnino C; Veglio F; Mulatero P; Monticone S
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874863
[TBL] [Abstract][Full Text] [Related]
26.
Zein J; Gaston B; Bazeley P; DeBoer MD; Igo RP; Bleecker ER; Meyers D; Comhair S; Marozkina NV; Cotton C; Patel M; Alyamani M; Xu W; Busse WW; Calhoun WJ; Ortega V; Hawkins GA; Castro M; Chung KF; Fahy JV; Fitzpatrick AM; Israel E; Jarjour NN; Levy B; Mauger DT; Moore WC; Noel P; Peters SP; Teague WG; Wenzel SE; Erzurum SC; Sharifi N
Proc Natl Acad Sci U S A; 2020 Jan; 117(4):2187-2193. PubMed ID: 31932420
[TBL] [Abstract][Full Text] [Related]
27. Endocrine disruptors of inhibiting testicular 3β-hydroxysteroid dehydrogenase.
Zhang S; Mo J; Wang Y; Ni C; Li X; Zhu Q; Ge RS
Chem Biol Interact; 2019 Apr; 303():90-97. PubMed ID: 30826252
[TBL] [Abstract][Full Text] [Related]
28. Differences in substrate and inhibitor kinetics of human type 1 and type 2 3beta-hydroxysteroid dehydrogenase are explained by the type 1 mutant, H156Y.
Thomas JL; Mason JI; Brandt S; Norris W
Endocr Res; 2002 Nov; 28(4):471-5. PubMed ID: 12530651
[TBL] [Abstract][Full Text] [Related]
29. HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer.
Alyamani M; Emamekhoo H; Park S; Taylor J; Almassi N; Upadhyay S; Tyler A; Berk MP; Hu B; Hwang TH; Figg WD; Peer CJ; Chien C; Koshkin VS; Mendiratta P; Grivas P; Rini B; Garcia J; Auchus RJ; Sharifi N
J Clin Invest; 2018 Aug; 128(8):3333-3340. PubMed ID: 29939161
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and Prognostic Value of the Polymorphic Variant 1245A>C of HSD3B1 in Castration-resistant Prostate Cancer.
Stangl-Kremser J; Lemberger U; Hassler MR; Bruchbacher A; Ilijazi D; Garstka N; Kramer G; Haitel A; Abufaraj M; Shariat SF
Clin Genitourin Cancer; 2019 Oct; 17(5):389-394. PubMed ID: 31331867
[TBL] [Abstract][Full Text] [Related]
31. Ziram inhibits aromatase activity in human placenta and JEG-3 cell line.
Chen L; Chen X; Chen X; Hu Z; Li X; Su Y; Li X; Ge RS
Steroids; 2017 Dec; 128():114-119. PubMed ID: 28951168
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of trilostane and cyanoketone on the 3 beta-hydroxysteroid dehydrogenase-isomerase reactions in androgen and 16-androstene biosynthetic pathways in the pig testis.
Cooke GM
J Steroid Biochem Mol Biol; 1996 Apr; 58(1):95-101. PubMed ID: 8809191
[TBL] [Abstract][Full Text] [Related]
33. The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancer.
Shiota M; Akamatsu S; Narita S; Sumiyoshi T; Fujiwara M; Uchiumi T; Ogawa O; Habuchi T; Eto M
Pharmacogenomics J; 2021 Aug; 21(4):440-445. PubMed ID: 33649516
[TBL] [Abstract][Full Text] [Related]
34. Stat5-mediated regulation of the human type II 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene: activation by prolactin.
Feltus FA; Groner B; Melner MH
Mol Endocrinol; 1999 Jul; 13(7):1084-93. PubMed ID: 10406460
[TBL] [Abstract][Full Text] [Related]
35. Effects of 4-MA, a potent inhibitor of 5 alpha-reductase, on 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase activity in guinea pig adrenals.
Perron S; Bélanger A
Steroids; 1994 Jun; 59(6):371-6. PubMed ID: 7940615
[TBL] [Abstract][Full Text] [Related]
36. HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond.
Sabharwal N; Sharifi N
Endocrinology; 2019 Sep; 160(9):2180-2188. PubMed ID: 31271415
[TBL] [Abstract][Full Text] [Related]
37. Association Between Adrenal-Restrictive HSD3B1 Inheritance and Hormone-Independent Subtypes of Endometrial and Breast Cancer.
McManus JM; Vargas R; Bazeley PS; Schumacher FR; Sharifi N
JNCI Cancer Spectr; 2022 Sep; 6(5):. PubMed ID: 35947687
[TBL] [Abstract][Full Text] [Related]
38. Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues.
Labrie F; Simard J; Luu-The V; Bélanger A; Pelletier G
J Steroid Biochem Mol Biol; 1992 Dec; 43(8):805-26. PubMed ID: 22217825
[TBL] [Abstract][Full Text] [Related]
39. Genetic variation in the HSD3B1 gene and recurrent spontaneous abortions.
Ntostis P; Peraki O; Boulgari A; Agiannitopoulos K; Pantos K; Lamnissou K
J Matern Fetal Neonatal Med; 2012 Apr; 25(4):408-10. PubMed ID: 21631238
[TBL] [Abstract][Full Text] [Related]
40. Activity and inhibition of 3-beta-hydroxysteroid dehydrogenase/delta-5-4-isomerase in human skin.
Tóth I; Szécsi M; Julesz J; Faredin I
Skin Pharmacol; 1997; 10(3):160-8. PubMed ID: 9287397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
